Diabetes 57:86-94, 2008 DOI: 10.2337/db07-0733 © 2008 by the American Diabetes Association
In Vivo Evidence for Inverse Agonism of Agouti-Related Peptide in the Central Nervous System of Proopiomelanocortin-Deficient Mice
1 Center for the Study of Weight Regulation and Associated Disorders, Oregon Health and Science University, Portland, Oregon Address correspondence and reprint requests to Virginie Tolle, PhD, UMR549 Inserm, IFR Broca-Ste Anne, 2 ter rue dAlesia, 75014 Paris, France. E-mail: virginie.tolle{at}broca.inserm.fr
Key Words: AgRP, Agouti-related peptide CART, cocaine and amphetamine–related transcript CNS, central nervous system CRH, corticotropin-releasing hormone DIO, diet-induced obesity MC-R, melanocortin receptor MC3-R, melanocortin-3 receptor MC4-R, melanocortin-4 receptor MSH, melanocyte-stimulating hormone MTII, melanotan II NPY, neuropeptide Y PLSD, protected least squares difference POMC, proopiomelanocortin RER, respiratory exchange ratio
OBJECTIVE—Melanocyte-stimulating hormone (MSH) peptides processed from proopiomelanocortin (POMC) regulate energy homeostasis by activating neuronal melanocortin receptor (MC-R) signaling. Agouti-related peptide (AgRP) is a naturally occurring MC-R antagonist but also displays inverse agonism at constitutively active melanocortin-4 receptor (MC4-R) expressed on transfected cells. We investigated whether AgRP functions similarly in vivo using mouse models that lack all neuronal MSH, thereby precluding competitive antagonism of MC-R by AgRP. RESEARCH DESIGN AND METHODS—Feeding and metabolic effects of the MC-R agonist melanotan II (MTII), AgRP, and ghrelin were investigated after intracerebroventricular injection in neural-specific POMC-deficient (Pomc–/–Tg/+) and global POMC-deficient (Pomc–/–) mice. Gene expression was quantified by RT-PCR. RESULTS—Hyperphagic POMC-deficient mice were more sensitive than wild-type mice to the anorectic effects of MTII. Hypothalamic melanocortin-3 (MC3)/4-R mRNAs in POMC-deficient mice were unchanged, suggesting increased receptor sensitivity as a possible mechanism for the heightened anorexia. AgRP reversed MTII-induced anorexia in both mutant strains, demonstrating its ability to antagonize MSH agonists at central MC3/4-R, but did not produce an acute orexigenic response by itself. The action of ghrelin was attenuated in Pomc–/–Tg/+ mice, suggesting decreased sensitivity to additional orexigenic signals. However, AgRP induced delayed and long-lasting modifications of energy balance in Pomc–/–Tg/+, but not glucocorticoid-deficient Pomc–/– mice, by decreasing oxygen consumption, increasing the respiratory exchange ratio, and increasing food intake. CONCLUSIONS—These data demonstrate that AgRP can modulate energy balance via a mechanism independent of MSH and MC3/4-R competitive antagonism, consistent with either inverse agonist activity at MC-R or interaction with a distinct receptor.
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||